T1	eligibility 588 643	Older women with invasive, non-metastatic breast cancer
T2	average-age 242 252	â‰¥ 65 years
T3	No-of-participants 647 650	150
T4	No-of-participants 656 659	530
T5	outcome 1013 1035	Anthracycline regimens
T6	outcome 1205 1228	global QoL at 24 months
T7	outcome 1429 1462	improvement in emotional function
T8	outcome 1541 1587	reductions in therapy side effects and fatigue
